HOME >> BIOLOGY >> NEWS
Oswaldo Cruz Foundation, Virginia Bioinformatics Institute sign agreement...

Blacksburg, Va., USA and Rio de Janeiro, Brazil, May 2, 2006, The Virginia Bioinformatics Institute (VBI) at Virginia Tech and the Oswaldo Cruz Foundation (FIOCRUZ) today signed an agreement to accelerate the development of new health products and technologies. The initial three-year agreement is intended to facilitate the development of drugs, vaccines, diagnostics and other technologies that may reduce the global burden of infectious diseases. The collaboration includes innovative research and development initiatives targeting healthcare solutions for dengue fever, hepatitis C, HIV/AIDS, influenza, malaria, and pneumonia (Mycoplasma pneumoniae).

FIOCRUZ, which has expertise in biology, medicine, clinical treatment and the epidemiology of infectious diseases, has developed infrastructure for the prevention, treatment and detection of endemic infectious diseases. VBI has developed genomics, proteomics and bioinformatics tools and data that can be readily applied to the study of infectious diseases as well as the discovery of new vaccine, drug and diagnostic targets. The partnership will therefore combine the growing ability of FIOCRUZ to develop and introduce new healthcare products with the computational and infectious disease research capabilities of VBI. In addition, both parties will engage in scientific, technical and educational collaborations that will serve to advance efforts to reduce disparities in global health.

Dr. Bruno Sobral, executive and scientific director of VBI, remarked: "This agreement reflects a compelling need for new ways to tackle the global threat of infectious diseases. It also represents what we see as a highly innovative framework for new partnerships in the public health arena." He added: "By signing this agreement, we are creating an enabling environment that allows VBI's strengths in computational resources, high-performance computing, bioinformatics and infectious disease research to be combined with the clinical e
'"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
2-May-2006


Page: 1 2 3

Related biology news :

1. Virginia Tech researchers to study poplar tree as model biomass crop
2. Fire ants are emerging nuisance for Virginians
3. Virginia Techs System X supercomputer provides super tool for simulation of cell division
4. Asian Soybean Rust found in Virginia, but not a threat to current crop
5. Virginia Tech chemists create new polymers by adding DNA base pairs
6. Pregnant drivers, football players safer thanks to a top Virginia Tech researcher
7. Virginia Tech student selected to meet Nobel Laureates
8. Virginia study urges early emphasis on science
9. Award supports Virginia Tech research to reduce vehicle emissions, create biofuel
10. Virginia Bioinformatics Institute to develop Tomato Metabolite Database
11. Virginia Tech to host Biodiversity Conservation in Agriculture Symposium

Post Your Comments:
(Date:10/31/2014)... New Haven, Conn. – Geologists are letting the air out ... on Earth. , Scientists have long speculated as to why ... Earth,s surface. Animals began to prosper at the end of ... what about the billion-year stretch before that, when most researchers ... seems the air wasn,t so great then, after all. , ...
(Date:10/31/2014)... good for attracting species, but it may not be enough ... study has found. , The researchers surveyed two types of ... abundance of two insects that interact with them. They found ... and black walnut, they didn,t find a corresponding abundance of ... the walnuts and black cherries and a type of wasp ...
(Date:10/31/2014)... Melbourne researchers have uncovered key steps involved in programmed ... diseases including lupus, cancers and neurodegenerative diseases. , ... Institute worked together to discover the three-dimensional structure of ... the first steps in how it causes cell death. ... and Proceedings of the National ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2A matter of life and death: Cell death proteins key to fighting disease 2
(Date:10/31/2014)... Brady (NYSE:BRC), a global ... a new video testimonial on the effectiveness ... a research technician at the BloodCenter of Wisconsin discusses ... and storing hundreds of thousands of samples, and how ... , “At Brady, we design our label materials with ...
(Date:10/31/2014)... 2014  Tavistock Development Co. (TDC), a diversified ... groundbreaking of the GuideWell Innovation Center ... The 92,000-square-foot, three-story facility is the first multi-tenant ... designed specifically for life sciences, health innovation, and ... 650-acre Lake Nona Medical City, near the Sanford-Burnham ...
(Date:10/30/2014)... Investor-Edge has initiated coverage on the following ... (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: ... and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on ... . On Wednesday, October 29, 2014, the ... Jones Industrial Average declined 0.18%, to finish the day ...
(Date:10/30/2014)... Dallas, Texas (PRWEB) October 30, 2014 ... China Naltrexone HCL Industry” is a professional and ... The report provides basic Naltrexone HCL information, including ... as well as industry overview. This research covers ... as well as global industry analysis covering macroeconomic ...
Breaking Biology Technology:Brady Debuts New Lab Label Testimonial Video 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
Cached News: